Valneva SE (VALN): Price and Financial Metrics

Valneva SE (VALN): $6.67

1.12 (-14.38%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add VALN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#74 of 337

in industry

VALN Price/Volume Stats

Current price $6.67 52-week high $9.50
Prev. close $7.79 52-week low $3.62
Day low $6.62 Volume 216,400
Day high $7.31 Avg. volume 67,383
50-day MA $4.89 Dividend yield N/A
200-day MA $6.34 Market Cap 542.01M

VALN Stock Price Chart Interactive Chart >


Valneva SE (VALN) Company Bio


Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium. The company also develops VLA15, a vaccine candidate that is in Phase II clinical trial against Borrelia; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; and VLA2001, a vaccine candidate that has completed Phase I/II clinical trial against SARS-CoV-2. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. The company has collaborations with Pfizer to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France.


VALN Latest News Stream


Event/Time News Detail
Loading, please wait...

VALN Latest Social Stream


Loading social stream, please wait...

View Full VALN Social Stream

VALN Price Returns

1-mo 52.63%
3-mo 46.27%
6-mo -15.74%
1-year -16.36%
3-year -80.15%
5-year N/A
YTD 52.56%
2024 -57.84%
2023 -18.48%
2022 -77.09%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!